Coalesce Research Group is pleased to announce the 3rd International Conference on Rare Diseases and Orphan Drugs set to take place on October 27–28 2025 in Singapore City Singapore. This two-day conference is designed to serve as a global platform for experts stakeholders and advocates to discuss advancements challenges and opportunities in the rare diseases and orphan drugs sector.
The primary objective of Rare Diseases 2025 is to raise awareness foster collaboration and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research drug development patient care advocacy and policy-making.
Event Venue
Singapore
